Tax data clustering

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Palantir Technologies Inc. patent solves the following problem:

Financial security and investigation in an analyst may have to make decisions about which data entities in a collection of data. For example, the analyst has to decide whether a data account company represents a fraudulent bank account. However, one company's data often contains insufficient information for the analyst to make such decisions.

Our analysis of this patent is as follows:

Palantir Technologies Inc.’s patent US 9171334 B1 deals with Tax data clustering.
In various embodiments, systems, methods, and procedures that declared the creation of a collection to help the relevant information from a seed. Seed can be generated based on the seed procedure or signature generation. Clusters can be generated by, for example, to recover from a seed, seed and adding a first cluster, taking a gathering methods or rules, and adding related data and / or data entities in the cluster based on the clustering method. Various balanced cluster may be generated based on the quality of the data in a cluster. Moreover, cluster metascores be generated based on various scores cluster associated with a cluster. Clusters can be ranked based on cluster metascores. Various embodiments may enable an analyst to discover the various insights relating to the assistance data, and can be used for various tasks including, for example, tax fraud detection, beaconing malware detection, malware user-agent detection, and / or activity trend detection, among various others.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Isogenis, Inc. patent solves the following problem:

adenoviruses

Our analysis of this patent is as follows:

Isogenis, Inc.’s patent US 9169493 B2 deals with Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof.
The embodiments disclosed in relation to the construction of all-thread Adenovirus-based gene delivery vector packaged without helper Adenovirus, and especially their use in gene therapy for gene and protein expression, vaccine development, and immunosuppressive therapy for allogeneic transplantation. In one picture, a method for propagating an adenoviral vector includes (a) providing an Adenovirus packaging cell line; (B) transfecting a full-thread Adenoviral vector construction of cell lines; and optionally (c) transfecting a packaging cell line construction, where the full-thread Adenoviral vector make and optionally the packaging conduct can transfect Adenovirus packaging cell line resulted in the encapsidation in a bug- os-thread Adenoviral vector independent helper Adenovirus. In one picture, a target cell transduced encapsidated full-thread Adenoviral vector to treat a condition, illness or a disease.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method and apparatus for an imaging system

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Futrfab, Inc patent solves the following problem:

One known method of advanced technology fabrication materials such as semi-conductor substrates are gathering at a manufacturing facility as a cleanroom. In these cleanrooms, processing device arranged to give way to space for human operators or automation equipment. Exemplary cleanroom design described in: Cleanroom Design, Second Edition, edited by W. white, published by John Wiley & sons, 1999, ISBN 0-471-94204-9, (here after referred to as white text in included for reference in its entirety).

Our analysis of this patent is as follows:

Futrfab, Inc’s patent US 9171697 B2 deals with Method and apparatus for an imaging system.
The present invention provides apparatus for an imaging system consisting of a multitude of imaging elements on a substrate. In some embodiments the substrate will be approximately round with a radius of approximately one inch. Various methods relating to the use of an imaging system mentioned.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Conserved Neisserial antigens

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Glaxosmithkline Biologicals Sa patent solves the following problem:

Neisseria meningitidis and Neisseria gonorrhoeae are non-motile, programs negative diplococci pathogenic to humans.

Our analysis of this patent is as follows:

Glaxosmithkline Biologicals Sa’s patent US 9169301 B2 deals with Conserved Neisserial antigens.
To ensure maximum cross-strain recognition and reactivity, protein regions conserved between different Neisserial species, serogroups and strains can be used. the invention provides proteins comprising stretches of amino acid sequences shared throughout most of Neisseria, particularly N. meningitidis and N. gonorrhoeae.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Production of antibody formats and immunological applications of said formats

File for Quick & Easy Patent Protection with PowerPatent.

The Centre National De La Recherche Scientifique-Cnrs, , Inserm (Institut National De La Sante Et De La Recherche Medicale), , Universite D’aix Marseille, , Universite De Montpellier, , Institut Regional du Cancer de Montpellier-Val d’Aurelle, , Institut Paoli Calmettes patent solves the following problem:

The invention relates to the production of antibody formats and their immunological applications, more specifically in immunotherapy and immunodiagnostic. The inventors call to mind that the antibody immunoglobulin molecule (Ig) that are 5 classes: IgM, IgG, IGD, IgE and IgA. In general, these molecules contain a heavy chain (H) and a light chain (L) is either Kappa chain (), or lambda chain ().

Our analysis of this patent is as follows:

Centre National De La Recherche Scientifique-Cnrs, , Inserm (Institut National De La Sante Et De La Recherche Medicale), , Universite D’aix Marseille, , Universite De Montpellier, , Institut Regional du Cancer de Montpellier-Val d’Aurelle, , Institut Paoli Calmettes’s patent US 9169316 B2 deals with Production of antibody formats and immunological applications of said formats.
the invention of an in-vitro method for identifying a target genome transformation into an oocyte or an egg and a method for performing a random insertion into the genome of a host cell.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Implantation of gaseous chemicals into cavities formed in intermediate dielectrics layers for subsequent thermal diffusion release

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Cavendish Kinetics, Inc. patent solves the following problem:

Embodiments of the present invention generally relates to the introduction of a gas into a micro hole to improve the lifetime of a micro-electromechanical system (MEMS) devices.

Our analysis of this patent is as follows:

Cavendish Kinetics, Inc.’s patent US 9171966 B2 deals with Implantation of gaseous chemicals into cavities formed in intermediate dielectrics layers for subsequent thermal diffusion release.
The present invention generally relates to methods for increasing the lifetime of MEMS devices by reducing the landing velocity of change by introducing gas into the hole around the switch elements in MEMS devices. The gas is introduced using ion implantation into a hole by hole housing the switch elements connected to the hole in a way through which the gas will come from a hole in one. The implant energy selected to implant many of the nearby atoms in the roof and floor of the hole that the annealing atoms diffuse into the hole. Gas provides gas damping that reduces the kinetic energy of the switch MEMS devices will need to have a longer lifetime.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Expression and assembly of human group C rotavirus-like particles and uses thereof

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The The United States Of America As Represented By The Secretary, Department Of Health And Human Services patent solves the following problem:

Rotavirus is a diverse group of pathogens classified into groups A through G based on different characteristics of the inner capsid protein, VP6. Among these, GPC RV recognized as a pathogen in humans and cause outbreaks and sporadic cases of gastroenteritis worldwide in young children <3 years of age (8, 13 , 15, 25, 26, 29, 30) and in older children and adults (2, 15, 20, 21, 25, 26, 30, 32). While some studies reported lower rates detection in children with diarrhea (1, 2, 4, 26, 29), seroprevalence study GPC RV is a common pathogen with a higher incidence of adults (4, 6, 10, 20, 27, 31).

Our analysis of this patent is as follows:

The United States Of America As Represented By The Secretary, Department Of Health And Human Services’s patent US 9169296 B2 deals with Expression and assembly of human group C rotavirus-like particles and uses thereof.
Group C rotavirus is a cause of acute gastroenteritis in children and adults separate from the group in an RV. However, a group of human P rotavirus not grow in culture, resulting in a lack of tools for the detection and treatment of disease GrpC RV. Therefore, the burden of GPC RV disease not clearly established. Isolated artificial human Rotavirus group C virus-like particles provided according to embodiments of the present invention and methods of their production and use, inter alia, detection GRP C RV infection, diagnostic assays and immunogenic compositions .

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Medical Diagnostic Laboratories, Llc patent solves the following problem:

Apparently the production of inflammatory cytokines such as IL-23 linked to a number of diseases including multiple sclerosis, asthma, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and psoriasis. Over 10 million people in the United States are affected with these IL-23 mediated diseases. Systemic levels of IL-23 associated with rheumatoid arthritis. (… Melis, et al, Ann Rheum Dis 69 :. 618-623, 2010). IL-23 gene knock-out mice that were resistant to development in many inflammatory diseases, indicating an important role for IL-23 in the pathogenesis of the disorder. (Langowski, et al, Nature, 442 :. 7101, 2006). Single nucleotide polymorphisms in the IL-23 receptor gene associated with psoriasis. (Capon et al, Hum genet 122: 201-6, 2007). A nucleotide polymorphism in the IL-23 receptor gene was found to be associated with Crohn's disease and inflammatory bowel disease. (Duerr, et al, Science, 314 .: 1461-1463, 2006).

Our analysis of this patent is as follows:

Medical Diagnostic Laboratories, Llc’s patent US 9169292 B2 deals with Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof.
The present invention relates to novel polypeptides that bind to IL-23 receptor and inhibit the amount of IL-23 to its corresponding receptor and cell signaling. The novel polypeptides of the present invention has a core structure WX1X2X3W, where K is tryptophan, and X1, X2 and X3 amino acids, with the proviso that when one of X1, X2 or X3 is K, remaining two of X1, x2 or X3 is impossible W. preferred core structures include WVDYW or WQDYW. The present invention relates to a composition comprising the novel polypeptides, and using the same for treating IL-23 associated disease in humans including, for example, inflammatory bowel disease, psoriasis and Crohn's disease.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Production and extraction of procyanidins from plant cell cultures

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The DianaPlantScience, Inc. patent solves the following problem:

Polyphenols are widely distributed in plants, fruits, and vegetables, and received much attention because of their physiological functions in human and animal health, including the antioxidant, antimutagenic and cancer prevention activities (salvia et al, J. Agric Food Chem 39:. 1549-1552, 1991; Bomser et al, Cancer Lett 135: 151-157, 1999; Zhao et al, Carcinogenesis, 20 :. 1737-1745, 1999). . Epidemiological studies suggest that flavonoids, among the polyphenols, may reduce the risk of heart disease (Hertog et al, Lancet .: 342: 1007-1011, 1993). Moreover, food flavan-3-OLS and / or proanthocyanidins shown to reduce the incidence of atherosclerosis and heart disease in experimental animals (Tijburg et al, Atherosclorosis, 135 :. 37-47, 1997; Yamakoshi et al, atherosclerosis., 142: 139-149, 1999). One of the mechanisms responsible for these effects include inhibition of oxidation of low density lipoprotein (LDL) (Steinberg, Circulation, 85: 2337-2344, 1992).

Our analysis of this patent is as follows:

DianaPlantScience, Inc.’s patent US 9167840 B2 deals with Production and extraction of procyanidins from plant cell cultures.
A method of preparing cocoa oligomeric procyanidins from cocoa cell cultures grown in the presence of monosaccharide can increase the production of procyanidins as follows: culturing cells enough to result in the production of cocoa oligomeric procyanidins in a first rate; and introducing a monosaccharide into cells sufficient to induce the cells to produce cocoa oligomeric procyanidins in a second rate that is higher than the initial rate. method can further include cocoa oligomeric procyanidins from the cells, and the RELEASE can occur between 1 day to 21 days after the introduction of monosaccharide. Optionally, the monosaccharide can be introduced in an amount of 0.5% to 20% in the number of culture medium. monosaccharide will be glucose, sucrose, fructose, or the like. monosaccharide can be introduced during or after a final of an exponential growth state.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method of optimizing a lithographic process, device manufacturing method, lithographic apparatus, computer program product and simulation apparatus

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Asml Netherlands B.V. patent solves the following problem:

A lithographic apparatus is a machine that applies a desired pattern onto a substrate, usually onto a target portion of the substrate. A lithographic apparatus can be used, for example, in the manufacture of integrated circuits (ICs). In time, a pattern maker, alternatively referred to as a mask or a reticle, can be used to generate a circuit pattern formed on an individual layer of the IC. This pattern can be transferred to a target segment (comprised of, one, or several dies) on a substrate (eg a silicon wafer). Transfer the pattern is usually by imaging onto a layer of radiation-sensitive material (resist) provided on the substrate. In general, a substrate consisting of a network of adjacent target portions that order followed. Known lithographic apparatus include so-called steppers, each target portion irradiated by exposing an entire pattern onto the target at a time, and so-called scanners, each target portion irradiated with scanning the pattern through a radiation beam in one direction (the scanning direction) while synchronously scanning the substrate parallel or anti-parallel to this direction. It is also possible to transfer the pattern from the following devices to the substrate by imprinting the pattern to the substrate.

Our analysis of this patent is as follows:

Asml Netherlands B.V.’s patent US 9170502 B2 deals with Method of optimizing a lithographic process, device manufacturing method, lithographic apparatus, computer program product and simulation apparatus.
One way to increase a lithographic process to form a pattern, including a plurality of parts, to a substrate using a lithographic apparatus, the lithographic apparatus with a controllable light system to illuminate a pattern device and controllable projection system to project an image of the following devices to the substrate, the method including selecting a portion of the plurality of parts, determining a light atmosphere for the light system to optimize imaging of choice, and to determine a projection position for the projection imaging systems to optimize the choice of taking into account the light conditions.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.